How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Vaccine Shipping Box Market
- By Material Type: Corrugated Fiberboard, Expanded Polystyrene (EPS) Foam, Polyurethane Foam, Plastic (Polypropylene, Polyethylene), Aluminum Foil Laminates
- By Temperature Control Technology: Passive Cooling (Gel Packs, Phase Change Materials), Active Cooling (Battery-Powered Refrigeration), Vacuum Insulated Panels (VIP), Dry Ice Packaging, Thermal Blankets
- By Box Configuration: Single-Use Shipping Boxes, Reusable Shipping Containers, Insulated Shippers, Modular Packaging Systems, Custom-Molded Inserts
- By End-User Industry: Pharmaceutical Manufacturers, Biotechnology Companies, Clinical Trial Organizations, Healthcare Providers, Cold Chain Logistics Providers
- By Vaccine Type Compatibility: mRNA Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Viral Vector Vaccines
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Corrugated Fiberboard leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Vaccine Shipping Box Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Material Type 5
Temperature Control Technology 5
Box Configuration 5
End-User Industry 5
Vaccine Type Compatibility 5
Companies profiled
Thermo Fisher Scientific
Pelican BioThermal
Sonoco ThermoSafe
CIT Packaging
Va-Q-Tec AG
Softbox Systems
Cryopak
Cold Chain Technologies
CSafe Global
Intelsius (a Pelican BioThermal brand)
Mitsubishi Heavy Industries Packaging
DHL Supply Chain (specialized in cold chain logistics)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Pelican BioThermal
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sonoco ThermoSafe
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →CIT Packaging
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Va-Q-Tec AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Softbox Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Cryopak
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Cold Chain Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →CSafe Global
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Intelsius (a Pelican BioThermal brand)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Mitsubishi Heavy Industries Packaging
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →DHL Supply Chain (specialized in cold chain logistics)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →FedEx Custom Critical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →UPS Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Marken (a UPS company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,679M by 2033 · 9.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Corrugated Fiberboard39.1
- Expanded Polystyrene (EPS) Foam12.6
- Polyurethane Foam13.4
- Plastic (Polypropylene, Polyethylene)13.2
- Aluminum Foil Laminates21.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$569.4M → $1,104M · 8.6%
Europe$396.8M → $789.5M · 9.0%
Asia Pacific$362.3M → $687.4M · 8.3%
Latin America$224.3M → $433.0M · 8.6%
Middle East and Africa$172.5M → $330.1M · 8.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.872026
9.892027
9.892028
9.922029
9.922030
9.932031
9.942032
9.962033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific19.9
- Pelican BioThermal23.7
- Sonoco ThermoSafe9.9
- CIT Packaging5.4
- Va-Q-Tec AG6.4
- Softbox Systems6.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type15.5%
Temperature Control Technology11.0%
Box Configuration27.7%
End-User Industry19.7%
Vaccine Type Compatibility26.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.0
- Europe23.6
- Asia Pacific20.6
- Latin America12.9
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 79 | 95 | 93 | 98 | 73 | 87 | 88 |
| Pelican BioThermal | 82 | 73 | 90 | 90 | 89 | 86 | 85 |
| Sonoco ThermoSafe | 70 | 68 | 84 | 84 | 84 | 73 | 77 |
| CIT Packaging | 61 | 66 | 78 | 73 | 70 | 68 | 69 |
| Va-Q-Tec AG | 60 | 55 | 71 | 68 | 59 | 71 | 64 |
| Softbox Systems | 54 | 51 | 71 | 53 | 48 | 65 | 57 |
| Cryopak | 46 | 61 | 60 | 65 | 54 | 42 | 55 |
| Cold Chain Technologies | 42 | 37 | 59 | 56 | 36 | 55 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Pelican BioThermal
- Sonoco ThermoSafe
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Pelican BioThermal | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Sonoco ThermoSafe | − | ◐ | ✓ | ◐ | ✓ | ◐ |
| CIT Packaging | − | ◐ | ◐ | ◐ | ✓ | ◐ |
| Va-Q-Tec AG | ◐ | − | − | ◐ | − | ◐ |
| Softbox Systems | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Cryopak | − | ◐ | − | ✓ | ◐ | − |
| Cold Chain Technologies | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific88
2Pelican BioThermal85
3Sonoco ThermoSafe77
4CIT Packaging69
5Va-Q-Tec AG64
6Softbox Systems57
7Cryopak55
8Cold Chain Technologies48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificPelican BioThermal
Challenger2
Strong scale, closing on the leaders.
Sonoco ThermoSafeCIT Packaging
Contender2
Focused players with pockets of strength.
Va-Q-Tec AGSoftbox Systems
Niche2
Specialists in a single segment or region.
CryopakCold Chain Technologies
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Vaccine Shipping Box Market — a $85M beachhead inside a $1.38B market.
Beachhead (SOM)$85Mobtainable near-term
Serviceable (SAM)$529Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Corrugated Fiberboard
Best fit — highest urgency & budget in Material Type.
Economic buyer81 fit
Expanded Polystyrene (EPS) Foam
Strong fit — clear ROI and a fast path to value.
End user66 fit
Polyurethane Foam
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Temperature Control Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Box Configuration
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Vaccine Shipping Box Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified22%
Evaluation12%
Closed-won7%
$9.8KCAC
$43KLTV
4.4:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Vaccine Shipping Box Market is a resilient opportunity — $1.50B by 2033, compounding at 4.6%.
TAM · 2025$1.04Btoday
TAM · 2033$1.50Bforecast
CAGR4.6%2027–2033
Cumulative$11.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.50BTotal addressable market
SAM$584MServiceable available market
SOM$104MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.6% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.50BLarge & growingTAM by 2033 at 4.6% CAGR
$584MServiceable nowreachable with today’s model
$104MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.17BBear3.0% CAGR
$1.50BBase4.6% CAGR
$1.92BBull6.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Temperature Control Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Vaccine Shipping Box Market — a $2.00B market by 2033. Plan: grow share from 10.7% to 18.2%.
Market size · 2033$2.00Btotal addressable
Market CAGR3.9%2027–2033
Target share18.2%from 10.7% today
Revenue ambition$364Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.7% | 18.2% | Behind |
| Revenue | $210M | $364M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 34.5% | 45.2% | On track |
| Customer retention | 85.7% | 92.0% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Temperature Control Technology capability
A defensible second engine — invest in Temperature Control Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Temperature Control Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $37M capacity & capability investment
- Greenlight bolt-on M&A in Temperature Control Technology
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Vaccine Shipping Box Market conversation — a $3.99B market you can size, segment and defend in minutes.
Market size · 2033$3.99Btotal opportunity
Growth9.1%CAGR to 2033
Addressable buyers1,486+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 3 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificPelican BioThermalSonoco ThermoSafeCIT PackagingVa-Q-Tec AGSoftbox SystemsCryopakCold Chain Technologies+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Vaccine Shipping Box Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Vaccine Shipping Box Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Vaccine Shippers Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportVaccines For Children (VFC) Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportVaccines Delivery Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportVaccines and Parasiticides for Pet Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportVaccines and Drugs for Duck Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportVaccines and Drugs for Chicken Market
Vaccines and Drugs for Chicken Market is valued at USD 3.12 Billion in 2025 and is expected to …
$3.1B market · 2025 base year
View reportVaccines Administered Orally Market
Market size, share, segmentation and regional forecast.
$880M market · 2025 base year
View reportVaccine Rubber Stopper Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportVaccine Refrigerated Warehousing Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportVaccine Refrigerant Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportVaccine Production Equipment Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportVaccine Packaging Container Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.